Literature DB >> 27367842

Glucocorticoid receptor-PPARα axis in fetal mouse liver prepares neonates for milk lipid catabolism.

Gianpaolo Rando1, Chek Kun Tan2, Nourhène Khaled1, Alexandra Montagner3, Nicolas Leuenberger1, Justine Bertrand-Michel4, Eeswari Paramalingam2, Hervé Guillou3, Walter Wahli1,2,3.   

Abstract

In mammals, hepatic lipid catabolism is essential for the newborns to efficiently use milk fat as an energy source. However, it is unclear how this critical trait is acquired and regulated. We demonstrate that under the control of PPARα, the genes required for lipid catabolism are transcribed before birth so that the neonatal liver has a prompt capacity to extract energy from milk upon suckling. The mechanism involves a fetal glucocorticoid receptor (GR)-PPARα axis in which GR directly regulates the transcriptional activation of PPARα by binding to its promoter. Certain PPARα target genes such as Fgf21 remain repressed in the fetal liver and become PPARα responsive after birth following an epigenetic switch triggered by β-hydroxybutyrate-mediated inhibition of HDAC3. This study identifies an endocrine developmental axis in which fetal GR primes the activity of PPARα in anticipation of the sudden shifts in postnatal nutrient source and metabolic demands.

Entities:  

Keywords:  FGF21; HDAC3; PPARα; developmental biology; glucocorticoid receptor; hepatic steatosis; ketone body; mouse; stem cells

Mesh:

Substances:

Year:  2016        PMID: 27367842      PMCID: PMC4963200          DOI: 10.7554/eLife.11853

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  42 in total

1.  Isolation of hepatoblasts based on the expression of Dlk/Pref-1.

Authors:  Naoki Tanimizu; Mitsuo Nishikawa; Hiroki Saito; Tohru Tsujimura; Atsushi Miyajima
Journal:  J Cell Sci       Date:  2003-05-01       Impact factor: 5.285

2.  Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity.

Authors:  Damir Zadravec; Annelie Brolinson; Rachel M Fisher; Claes Carneheim; Robert I Csikasz; Justine Bertrand-Michel; Jan Borén; Hervé Guillou; Mats Rudling; Anders Jacobsson
Journal:  FASEB J       Date:  2010-07-06       Impact factor: 5.191

3.  Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice.

Authors:  Amena Archer; Nicolas Venteclef; Agneta Mode; Matteo Pedrelli; Chiara Gabbi; Karine Clément; Paolo Parini; Jan-Åke Gustafsson; Marion Korach-André
Journal:  Mol Endocrinol       Date:  2012-10-16

Review 4.  The composition of human milk.

Authors:  R Jenness
Journal:  Semin Perinatol       Date:  1979-07       Impact factor: 3.300

5.  Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis.

Authors:  Qiaozhu Su; Chris Baker; Patricia Christian; Mark Naples; Xuedong Tong; Kezhong Zhang; Miklos Santha; Khosrow Adeli
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-04-15       Impact factor: 4.310

Review 6.  Energy metabolism in developing brain cells.

Authors:  J Edmond
Journal:  Can J Physiol Pharmacol       Date:  1992       Impact factor: 2.273

7.  Quantitative gas-liquid chromatographic analysis of rodent milk triglycerides.

Authors:  S Smith; R Watts; R Dils
Journal:  J Lipid Res       Date:  1968-01       Impact factor: 5.922

8.  Angiopoietin-like 4 (Angptl4): A glucocorticoid-dependent gatekeeper of fatty acid flux during fasting.

Authors:  Suneil K Koliwad; Nora E Gray; Jen-Chywan Wang
Journal:  Adipocyte       Date:  2012-07-01       Impact factor: 4.534

9.  Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.

Authors:  Jing Xu; David J Lloyd; Clarence Hale; Shanaka Stanislaus; Michelle Chen; Glenn Sivits; Steven Vonderfecht; Randy Hecht; Yue-Sheng Li; Richard A Lindberg; Jin-Long Chen; Dae Young Jung; Zhiyou Zhang; Hwi-Jin Ko; Jason K Kim; Murielle M Véniant
Journal:  Diabetes       Date:  2008-10-07       Impact factor: 9.461

10.  Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.

Authors:  Alexandra Montagner; Arnaud Polizzi; Edwin Fouché; Simon Ducheix; Yannick Lippi; Frédéric Lasserre; Valentin Barquissau; Marion Régnier; Céline Lukowicz; Fadila Benhamed; Alison Iroz; Justine Bertrand-Michel; Talal Al Saati; Patricia Cano; Laila Mselli-Lakhal; Gilles Mithieux; Fabienne Rajas; Sandrine Lagarrigue; Thierry Pineau; Nicolas Loiseau; Catherine Postic; Dominique Langin; Walter Wahli; Hervé Guillou
Journal:  Gut       Date:  2016-02-01       Impact factor: 23.059

View more
  16 in total

Review 1.  Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Authors:  Karolien De Bosscher; Sofie J Desmet; Dorien Clarisse; Eva Estébanez-Perpiña; Luc Brunsveld
Journal:  Nat Rev Endocrinol       Date:  2020-04-17       Impact factor: 43.330

2.  Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α.

Authors:  Joseph S Marino; Lance A Stechschulte; David E Stec; Andrea Nestor-Kalinoski; Sydni Coleman; Terry D Hinds
Journal:  J Biol Chem       Date:  2016-10-26       Impact factor: 5.157

Review 3.  Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Cell Metab       Date:  2017-02-07       Impact factor: 27.287

4.  RNA sequencing reveals niche gene expression effects of beta-hydroxybutyrate in primary myotubes.

Authors:  Philip Mm Ruppert; Lei Deng; Guido Jej Hooiveld; Roland Wj Hangelbroek; Anja Zeigerer; Sander Kersten
Journal:  Life Sci Alliance       Date:  2021-08-18

5.  Metabolic and Signaling Roles of Ketone Bodies in Health and Disease.

Authors:  Patrycja Puchalska; Peter A Crawford
Journal:  Annu Rev Nutr       Date:  2021-10-11       Impact factor: 9.323

Review 6.  Regulation of Ketone Body Metabolism and the Role of PPARα.

Authors:  Maja Grabacka; Malgorzata Pierzchalska; Matthew Dean; Krzysztof Reiss
Journal:  Int J Mol Sci       Date:  2016-12-13       Impact factor: 5.923

7.  Epigenetic modulation of Fgf21 in the perinatal mouse liver ameliorates diet-induced obesity in adulthood.

Authors:  Xunmei Yuan; Kazutaka Tsujimoto; Koshi Hashimoto; Kenichi Kawahori; Nozomi Hanzawa; Miho Hamaguchi; Takami Seki; Makiko Nawa; Tatsuya Ehara; Yohei Kitamura; Izuho Hatada; Morichika Konishi; Nobuyuki Itoh; Yoshimi Nakagawa; Hitoshi Shimano; Takako Takai-Igarashi; Yasutomi Kamei; Yoshihiro Ogawa
Journal:  Nat Commun       Date:  2018-02-12       Impact factor: 14.919

Review 8.  Regulation of maternal-fetal metabolic communication.

Authors:  Caitlyn E Bowman; Zoltan Arany; Michael J Wolfgang
Journal:  Cell Mol Life Sci       Date:  2020-10-21       Impact factor: 9.261

9.  Fetal Cardiac Lipid Sensing Triggers an Early and Sex-related Metabolic Energy Switch in Intrauterine Growth Restriction.

Authors:  Loïze Maréchal; Benoit Sicotte; Véronique Caron; Michèle Brochu; André Tremblay
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

10.  A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response.

Authors:  Alison Iroz; Alexandra Montagner; Fadila Benhamed; Françoise Levavasseur; Arnaud Polizzi; Elodie Anthony; Marion Régnier; Edwin Fouché; Céline Lukowicz; Michèle Cauzac; Emilie Tournier; Marcio Do-Cruzeiro; Martine Daujat-Chavanieu; Sabine Gerbal-Chalouin; Véronique Fauveau; Solenne Marmier; Anne-Françoise Burnol; Sandra Guilmeau; Yannick Lippi; Jean Girard; Walter Wahli; Renaud Dentin; Hervé Guillou; Catherine Postic
Journal:  Cell Rep       Date:  2017-10-10       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.